Holdings of Franklin Genomic Advancements ETF
Franklin Templeton ETF Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 27.9M $ including 27.3M $ in equities, 97.9 %
- Positions
- 60 in 8 countries
- Top ten
- 47.1 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | GUARDANT HEALTH INC | 16,927 | 2.5M $ | 9.09 % |
| 2 | NATERA INC | 7,679 | 2.1M $ | 7.46 % |
| 3 | Krystal Biotech Inc | 4,757 | 1.8M $ | 6.33 % |
| 4 | Ligand Pharmaceuticals Inc | 4,085 | 1.3M $ | 4.62 % |
| 5 | Adaptive Biotechnologies Corp | 51,956 | 1.1M $ | 3.99 % |
| 6 | United Therapeutics Corp | 1,809 | 980.2K $ | 3.51 % |
| 7 | Bridgebio Pharma Inc | 13,129 | 977.8K $ | 3.50 % |
| 8 | Eli Lilly & Co | 688 | 825.2K $ | 2.95 % |
| 9 | TWIST BIOSCIENCE CORP | 7,736 | 795.9K $ | 2.85 % |
| 10 | Vertex Pharmaceuticals Inc | 1,545 | 767.4K $ | 2.75 % |
| 11 | AstraZeneca PLC | 3,979 | 754.5K $ | 2.70 % |
| 12 | TRAVERE THERAPEUTICS INC | 12,753 | 724.5K $ | 2.59 % |
| 13 | Insmed Inc | 6,388 | 681.1K $ | 2.44 % |
| 14 | Samsung Biologics Co Ltd | 702 | 630.3K $ | 2.26 % |
| 15 | Corteva Inc | 7,435 | 629.7K $ | 2.25 % |
| 16 | Medpace Holdings Inc | 1,133 | 600K $ | 2.15 % |
| 17 | ALNYLAM PHARMACEUTICALS INC | 1,816 | 546.7K $ | 1.96 % |
| 18 | Tempus AI Inc | 9,397 | 544.4K $ | 1.95 % |
| 19 | IONIS PHARMACEUTICALS INC | 6,739 | 534.3K $ | 1.91 % |
| 20 | Neurocrine Biosciences Inc | 3,058 | 515.4K $ | 1.84 % |
| 21 | Regeneron Pharmaceuticals Inc | 805 | 501.9K $ | 1.80 % |
| 22 | Veracyte Inc | 7,819 | 459.2K $ | 1.64 % |
| 23 | Argenx SE | 494 | 458.3K $ | 1.64 % |
| 24 | PTC Therapeutics Inc | 5,009 | 408.6K $ | 1.46 % |
| 25 | BioNTech SE | 4,156 | 386.7K $ | 1.38 % |
| 26 | Stoke Therapeutics Inc | 11,349 | 371.3K $ | 1.33 % |
| 27 | Charles River Laboratories International Inc | 1,556 | 352.9K $ | 1.26 % |
| 28 | GRAIL Inc | 4,456 | 304.2K $ | 1.09 % |
| 29 | AnaptysBio Inc | 4,290 | 289.6K $ | 1.04 % |
| 30 | CRISPR Therapeutics AG | 5,030 | 274.3K $ | 0.98 % |
| 31 | Repligen Corp | 2,009 | 274.1K $ | 0.98 % |
| 32 | Cadence Design Systems Inc | 725 | 272.1K $ | 0.97 % |
| 33 | Beam Therapeutics Inc | 7,577 | 260K $ | 0.93 % |
| 34 | Praxis Precision Medicines Inc | 718 | 240.4K $ | 0.86 % |
| 35 | Axsome Therapeutics Inc | 936 | 229.1K $ | 0.82 % |
| 36 | CareDx Inc | 8,000 | 228K $ | 0.82 % |
| 37 | JAZZ PHARMACEUTICALS PLC | 905 | 218.1K $ | 0.78 % |
| 38 | Catalyst Pharmaceuticals Inc | 6,865 | 215.8K $ | 0.77 % |
| 39 | Thermo Fisher Scientific Inc | 421 | 211.1K $ | 0.76 % |
| 40 | IQVIA Holdings Inc | 1,082 | 209.1K $ | 0.75 % |
| 41 | Hinge Health Inc | 2,349 | 195K $ | 0.70 % |
| 42 | Ultragenyx Pharmaceutical Inc | 5,131 | 171.3K $ | 0.61 % |
| 43 | Agilent Technologies Inc | 1,223 | 162.5K $ | 0.58 % |
| 44 | Danaher Corp | 842 | 160.4K $ | 0.57 % |
| 45 | QIAGEN NV | 3,419 | 133.7K $ | 0.48 % |
| 46 | Rhythm Pharmaceuticals Inc | 1,048 | 116.4K $ | 0.42 % |
| 47 | Arcutis Biotherapeutics Inc | 4,422 | 115.9K $ | 0.42 % |
| 48 | Samsung Episholdings Co Ltd | 376 | 104.4K $ | 0.37 % |
| 49 | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | 1,479 | 94.6K $ | 0.34 % |
| 50 | TARSUS PHARMACEUTICALS INC | 1,136 | 71.5K $ | 0.26 % |
| 51 | Bio-Rad Laboratories Inc | 243 | 71.3K $ | 0.26 % |
| 52 | Liquidia Corp | 871 | 69.4K $ | 0.25 % |
| 53 | Bristol-Myers Squibb Co | 1,196 | 68.9K $ | 0.25 % |
| 54 | TG THERAPEUTICS INC | 1,253 | 68.8K $ | 0.25 % |
| 55 | BEONE MEDICINES LTD | 225 | 64.1K $ | 0.23 % |
| 56 | Neurogene Inc | 1,981 | 62.3K $ | 0.22 % |
| 57 | First Tracks Biotherapeutics Inc | 2,775 | 55.8K $ | 0.20 % |
| 58 | GeneDx Holdings Corp | 575 | 39.5K $ | 0.14 % |
| 59 | WAVE LIFE SCIENCES LTD | 4,813 | 28K $ | 0.10 % |
| 60 | Recursion Pharmaceuticals Inc | 5,507 | 20.2K $ | 0.07 % |
Sector breakdown
- Health care 32.7 %
- Materials 2.3 %
- Technology 1.0 %
- Unattributed 64.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 95.6 %
- KRW 2.7 %
- EUR 1.7 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 89.6 %
- United Kingdom 2.8 %
- South Korea 2.7 %
- Belgium 1.7 %
- Germany 1.4 %
- Switzerland 1.0 %
- Ireland 0.8 %
- Singapore 0.1 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 52 | 24.5M $ | 89.56 % |
| 2 | United Kingdom | 1 | 754.5K $ | 2.76 % |
| 3 | South Korea | 2 | 734.6K $ | 2.69 % |
| 4 | Belgium | 1 | 458.3K $ | 1.68 % |
| 5 | Germany | 1 | 386.7K $ | 1.41 % |
| 6 | Switzerland | 1 | 274.3K $ | 1.00 % |
| 7 | Ireland | 1 | 218.1K $ | 0.80 % |
| 8 | Singapore | 1 | 28K $ | 0.10 % |
Cite this page
Titelia. "Holdings of Franklin Genomic Advancements ETF". https://titelia.com/en/funds/S000067393